? CORE H The mission of the Providence-Boston CFAR Basic and Translational Sciences Core (BTSC) is to build and support collaborative research between basic, translational, clinical and behavioral investigators with a focus on NIH HIV/AIDS high priority areas including HIV pathogenesis, transmission and disease progression in key populations. A major priority of the BTSC is to provide services that extend the capacity of investigators, who lack the technical expertise or laboratory resources for their studies. The BTSC was restructured to take advantage of the partnership between Lifespan/Brown and Boston University Medical Campus (BUMC) and these institutions' strengths in basic and translational sciences. This new partnership significantly enhances the basic science expertise of the Core and of the CFAR, as well as its user pool and basic science institutional support. The BTSC will provide flexible services to HIV/AIDS researchers based on evolving needs as determined through regular surveys, and significantly expand the Core user pool through outreach and education. The BTSC will enhance its technical capacity by sharing expertise and centralizing labor-intensive tasks. Importantly, the BTSC will take an active role in identifying, consulting, mentoring and training investigators, particularly new investigators across the CFAR as well as established investigators who wish to expand into HIV research. The BTSC will promote collaborative basic and translational research through three specific aims: 1) Support HIV research by providing essential laboratory assays and expertise; 2) Develop and support innovative services and new collaborations; 3) Provide training and mentorship to local, national and international investigators with a wide range of HIV experience. Overall, the Core will provide CFAR users services and a scientific infrastructure dedicated to innovative, multidisciplinary basic science and translational HIV/AIDS research, and the guidance to strengthen capacity for laboratory-associated HIV/AIDS research training and education around the world.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-22
Application #
9953987
Study Section
Special Emphasis Panel (ZAI1)
Project Start
1998-09-01
Project End
2023-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Dong, Kimberly R; Tang, Alice M; Stopka, Thomas J et al. (2018) Food acquisition methods and correlates of food insecurity in adults on probation in Rhode Island. PLoS One 13:e0198598
Kerrigan, Andrew; Kaonga, Nadi N; Tang, Alice M et al. (2018) Content guidance for mobile phones short message service (SMS)-based antiretroviral therapy adherence and appointment reminders: a review of the literature. AIDS Care :1-11
Kantor, Rami; DeLong, Allison; Schreier, Leeann et al. (2018) HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya. AIDS 32:2485-2496
Ji, Hezhao; Enns, Eric; Brumme, Chanson J et al. (2018) Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus. J Int AIDS Soc 21:e25193
Murphy, Matthew; Berns, Abby L; Bandyopadhyay, Utpala et al. (2018) Varicella in the prison setting: A report of three outbreaks in Rhode Island and a review of the literature. Vaccine 36:5651-5656
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens. J Clin Microbiol 56:
Peloquin, Charles A; Phillips, Patrick P J; Mitnick, Carole D et al. (2018) Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. Antimicrob Agents Chemother 62:
Linas, Benjamin P; Nolen, Shayla (2018) A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am 32:447-459
Carroll, Jennifer J; Rich, Josiah D; Green, Traci C (2018) The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible. J Addict Med 12:459-465
Coleman, Sharon M; Gnatienko, Natalia; Lloyd-Travaglini, Christine A et al. (2018) False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts. HIV Clin Trials 19:15-22

Showing the most recent 10 out of 806 publications